Acute Adverse Reactions to Gadolinium-based Intravenous Contrast Agents for MRI : Retrospective Analysis Using Computed Reporting System |
Choi, Moon-Hyung
(Department of Radiology, Seoul St. Mary's Hospital, The Catholic University of Korea)
Choi, Joon-Il (Department of Radiology, Seoul St. Mary's Hospital, The Catholic University of Korea) Jung, Seung-Eun (Department of Radiology, Seoul St. Mary's Hospital, The Catholic University of Korea) Ahn, Kook-Jin (Department of Radiology, Seoul St. Mary's Hospital, The Catholic University of Korea) Lee, Hae-Giu (Department of Radiology, Seoul St. Mary's Hospital, The Catholic University of Korea) |
1 | Forsting M, Palkowitsch P. Prevalence of acute adverse reactions to gadobutrol--a highly concentrated macrocyclic gadolinium chelate: review of 14,299 patients from observational trials. Eur J Radiol 2010;74:e186-192 DOI ScienceOn |
2 | Bluemke DA, Sahani D, Amendola M, et al. Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study. Radiology 2005;237:89-98 DOI ScienceOn |
3 | Lalli AF. Contrast media reactions: data analysis and hypothesis. Radiology 1980;134:1-12 |
4 | Gonen M, Panageas KS, Larson SM. Statistical issues in analysis of diagnostic imaging experiments with multiple observations per patient. Radiology 2001;221:763-767 DOI ScienceOn |
5 | Shellock FG, Parker JR, Pirovano G, et al. Safety characteristics of gadobenate dimeglumine: clinical experience from intraand interindividual comparison studies with gadopentetate dimeglumine. J Magn Reson Imaging 2006;24:1378-1385 DOI ScienceOn |
6 | Murphy KP, Szopinski KT, Cohan RH, Mermillord B, Ellis JH. Occurrence of adverse reactions to gadolinium-based contrast material and management of patients at increased risk: a survey of the American Society of Neuroradiology Fellowship Directors. Acad Radiol 1999;6:656-664 DOI ScienceOn |
7 | Knopp MV, Balzer T, Esser M, Kashanian FK, Paul P, Niendorf HP. Assessment of utilization and pharmacovigilance based on spontaneous adverse event reporting of gadopentetate dimeglumine as a magnetic resonance contrast agent after 45 million administrations and 15 years of clinical use. Invest Radiol 2006;41:491-499 DOI ScienceOn |
8 | Abujudeh HH, Kosaraju VK, Kaewlai R. Acute adverse reactions to gadopentetate dimeglumine and gadobenate dimeglumine: experience with 32,659 injections. AJR Am J Roentgenol 2010;194:430-434 DOI ScienceOn |
9 | Morgan DE, Spann JS, Lockhart ME, Winningham B, Bolus DN. Assessment of adverse reaction rates during gadoteridolenhanced MR imaging in 28,078 patients. Radiology 2011;259:109-116 DOI ScienceOn |
10 | Niendorf HP, Dinger JC, Haustein J, Cornelius I, Alhassan A, Clauss W. Tolerance data of Gd-DTPA: a review. Eur J Radiol 1991;13:15-20 DOI ScienceOn |
11 | Dillman JR, Ellis JH, Cohan RH, Strouse PJ, Jan SC. Frequency and severity of acute allergic-like reactions to gadolinium-containing i.v. contrast media in children and adults. AJR Am J Roentgenol 2007;189:1533-1538 DOI |
12 | Nelson KL, Gifford LM, Lauber-Huber C, Gross CA, Lasser TA. Clinical safety of gadopentetate dimeglumine. Radiology 1995;196:439-443 |
13 | Murphy KJ, Brunberg JA, Cohan RH. Adverse reactions to gadolinium contrast media: a review of 36 cases. AJR Am J Roentgenol 1996;167:847-849 |
14 | Li A, Wong CS, Wong MK, Lee CM, Au Yeung MC. Acute adverse reactions to magnetic resonance contrast media--gadolinium chelates. Br J Radiol 2006;79:368-371 DOI ScienceOn |
15 | Bleicher AG, Kanal E. Assessment of adverse reaction rates to a newly approved MRI contrast agent: review of 23,553 administrations of gadobenate dimeglumine. AJR Am J Roentgenol 2008;191:W307-311 DOI |
16 | Marckmann P, Skov L, Rossen K, et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast- enhanced magnetic resonance imaging. J Am Soc Nephrol 2006;17:2359-2362 DOI ScienceOn |
17 | Tne American College of Radiology. Manual on contrast media version 7 2010. www.acr.org/SecondaryMainMenuCategories/quality_safety/contrast_manual/FullManual.aspx |
18 | Sadowski EA, Bennett LK, Chan MR, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 2007;243:148-157 DOI ScienceOn |